0I8F Stock Chart & Stats
$13.26
$0.13(1.00%)
At close: 4:00 PM EDT
$13.26
$0.13(1.00%)
Day’s Range― - ―
52-Week Range$8.84 - $14.66
Previous CloseN/A
Volume5.22K
Average Volume (3M)4.38K
Market Cap
$1.79B
Enterprise Value$4.20K
Total Cash (Recent Filing)$239.00M
Total Debt (Recent Filing)$2.31B
Price to Earnings (P/E)―
Beta1.67
Next Earnings
Oct 29, 2026EPS Estimate
0.32Next Dividend Ex-DateN/A
Dividend Yield7.2%
Share Statistics
EPS (TTM)-2.74
Shares Outstanding199,353,880
10 Day Avg. Volume6,231
30 Day Avg. Volume4,375
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)1.70
Price to Sales (P/S)0.62
P/FCF Ratio21.91
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$13.13Price Target Upside-1.02% Downside
Rating ConsensusHold
Number of Analyst Covering11
EPS Forecast (FY)1.53
Revenue Forecast (FY)$3.57B
Bulls Say, Bears Say
Bulls Say
Diversified Recurring Dental PortfolioDentsply Sirona serves multiple dental disciplines with both repeat-use consumables and higher-value equipment, reducing reliance on one product category. Its installed equipment base can also support follow-on consumable, software, maintenance and service revenue over time.
Positive Operating Cash GenerationPositive operating cash flow in every period shown and positive trailing free cash flow provide internal funding for operations and strategic investment. Although cash conversion is not yet sufficient to offset losses fully, ongoing generation offers resilience while the business works through its turnaround.
Wellspect Product-led GrowthWellspect's growth demonstrates that new product launches, broader geographic reach and customer adoption can produce momentum within the portfolio. This offers a tangible growth engine and supports management's broader return-to-growth plan beyond the company's weaker segments.
Bears Say
Persistent Revenue ContractionRepeated revenue declines indicate that demand and volume pressure remain broader than a single-quarter issue. Continued contraction can weaken operating leverage, reduce resources available for innovation and make the company's return-to-growth investments harder to translate into durable earnings.
Negative ProfitabilityOngoing net losses show that the company's otherwise intact gross-margin economics are not yet producing sustainable bottom-line returns. Persistent unprofitability limits retained capital, weakens return measures and leaves less cushion to absorb further demand, pricing or operating-cost pressure.
Elevated Leverage Limits FlexibilityThe materially higher debt burden reduces financial flexibility while earnings remain weak. Interest and refinancing obligations can compete with investment in sales, education and R&D, while elevated leverage makes any prolonged operating downturn more difficult to manage.
DENTSPLY SIRONA News
0I8F FAQ
What was DENTSPLY SIRONA Inc’s price range in the past 12 months?
DENTSPLY SIRONA Inc lowest share price was $8.84 and its highest was $14.66 in the past 12 months.
What is DENTSPLY SIRONA Inc’s market cap?
DENTSPLY SIRONA Inc’s market cap is $1.79B.
When is DENTSPLY SIRONA Inc’s upcoming earnings report date?
DENTSPLY SIRONA Inc’s upcoming earnings report date is Oct 29, 2026 which is in 28 days.
How were DENTSPLY SIRONA Inc’s earnings last quarter?
DENTSPLY SIRONA Inc released its earnings results on Aug 06, 2026. The company reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.348 by $0.172.
Is DENTSPLY SIRONA Inc overvalued?
According to Wall Street analysts DENTSPLY SIRONA Inc’s price is currently Overvalued.
Does DENTSPLY SIRONA Inc pay dividends?
DENTSPLY SIRONA Inc pays a Quarterly dividend of $0.16 which represents an annual dividend yield of 7.2%. See more information on DENTSPLY SIRONA Inc dividends here
What is DENTSPLY SIRONA Inc’s EPS estimate?
DENTSPLY SIRONA Inc’s EPS estimate is 0.32.
How many shares outstanding does DENTSPLY SIRONA Inc have?
DENTSPLY SIRONA Inc has 199,353,880 shares outstanding.
What happened to DENTSPLY SIRONA Inc’s price movement after its last earnings report?
DENTSPLY SIRONA Inc reported an EPS of $0.52 in its last earnings report, beating expectations of $0.348. Following the earnings report the stock price went down -9.278%.
Which hedge fund is a major shareholder of DENTSPLY SIRONA Inc?
Currently, no hedge funds are holding shares in GB:0I8F
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DENTSPLY SIRONA Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$13.13 (-1.02% Downside)
$13.13 (-1.02% Downside)
Blogger Sentiment
Neutral
GB:0I8F Sentiment 83%
Sector Average 65%
Sector Average 65%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.17%
12-Months-Change
Fundamentals
Return on Equity
7.20%
Trailing 12-Months
Asset Growth
-14.25%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
0I8F Company Deck
0I8F Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call reflected a mixed but constructive tone: management reported near-term top-line pressures across multiple segments (notably OIS and consumables distributor headwinds in EMEA) and acknowledged tariff and geopolitical uncertainties. Offsetting these challenges were stable adjusted EBITDA and EPS, a one-time $44 million tariff refund that materially improved cash flow and EPS, continued strategic investments in sales, clinical education and R&D, expansion of dealer partnerships, and strong Wellspect performance. Management maintained full-year guidance and emphasized that improvements from the return-to-growth action plan should become more visible in Q4 and into 2027. Given balanced operational progress and strategic momentum against ongoing revenue and regional demand headwinds, the overall message is cautiously optimistic but still in turnaround mode.View all GB:0I8F earnings summaries0I8F Net sales Breakdown
15.71% Equipment & Instruments
12.45% CAD/CAM
39.92% Essential Dental Solutions
6.17% Orthodontics
16.93% Implants & Prosthetics
8.83% Wellspect Healthcare
0I8F Stock 12 Month Forecast
Average Price Target
$13.13
▼(-1.02% Downside)